Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
100.60
-0.79 (-0.78%)
At close: Dec 30, 2025, 4:00 PM EST
102.56
+1.96 (1.95%)
After-hours: Dec 30, 2025, 7:04 PM EST
Guardant Health Revenue
Guardant Health had revenue of $265.20M in the quarter ending September 30, 2025, with 38.50% growth. This brings the company's revenue in the last twelve months to $902.57M, up 30.38% year-over-year. In the year 2024, Guardant Health had annual revenue of $739.02M with 31.04% growth.
Revenue (ttm)
$902.57M
Revenue Growth
+30.38%
P/S Ratio
13.84
Revenue / Employee
$446,595
Employees
2,021
Market Cap
12.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 739.02M | 175.07M | 31.04% |
| Dec 31, 2023 | 563.95M | 114.41M | 25.45% |
| Dec 31, 2022 | 449.54M | 75.89M | 20.31% |
| Dec 31, 2021 | 373.65M | 86.92M | 30.32% |
| Dec 31, 2020 | 286.73M | 72.36M | 33.75% |
| Dec 31, 2019 | 214.38M | 123.74M | 136.52% |
| Dec 31, 2018 | 90.64M | 40.80M | 81.85% |
| Dec 31, 2017 | 49.84M | 24.59M | 97.40% |
| Dec 31, 2016 | 25.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GH News
- 1 day ago - Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 1 day ago - Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening - Business Wire
- 6 days ago - Where To Invest In 2026: Top 5 Secular Growth Trends - Seeking Alpha
- 19 days ago - Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. - Business Wire
- 21 days ago - Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy - Business Wire
- 25 days ago - Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium - Business Wire
- 4 weeks ago - Senator Buys Coca-Cola, Hershey's Stock After Selling Magnificent Seven Stocks In 2025 - Benzinga
- 4 weeks ago - 5 Top Stocks For AI Fatigue - Seeking Alpha